Cargando…
Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up
The manufacture of recombinant therapeutics is a fastest-developing section of therapeutic pharmaceuticals and presently plays a significant role in disease management. Yeasts are established eukaryotic host for heterologous protein production and offer distinctive benefits in synthesising pharmaceu...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246677/ https://www.ncbi.nlm.nih.gov/pubmed/34193127 http://dx.doi.org/10.1186/s12934-021-01617-z |